Latest Articles

Publication Date
Endometrial HOXA-10, HOXA-11, ß-1 integrin, ECM-1, FAK, and CD44 immunohistochemical expressions in endometriosis-related recurrent IVF failure: a retrospective case-control study.

Published: April 20, 2026, midnight
Macrophage membrane-biomimetic nanovehicles delivering amygdalin halt pyroptosis propagation and alleviate endometriosis-associated neuropathic pain.

The clinical management of endometriosis encounters a significant obstacle: existing therapies inadequately address both the inhibition of ectopic lesion proliferation and the mitigation of the neuroinflammation associated with chronic pain. …

Published: April 20, 2026, midnight
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily

BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily

Published: April 18, 2026, 6:23 p.m.
Polypoid endometriosis mimicking aggressive pelvic malignancy on MRI in a premenopausal woman: A case report.

Polypoid endometriosis is a rare benign variant of endometriosis characterized by exuberant mass-forming endometrial tissue that can closely mimic aggressive pelvic malignancy on imaging. Although it most commonly affects peri- …

Published: April 18, 2026, midnight
SGO 2026: Ovarian OS Gains and New Endometrial Targets - Medscape

SGO 2026: Ovarian OS Gains and New Endometrial Targets Medscape

Published: April 17, 2026, 6:56 p.m.
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times

Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer Pharmacy Times

Published: April 17, 2026, 12:30 p.m.
Navigating the Clinical and Economic Burden of Endometrial Cancer - Pharmacy Times

Navigating the Clinical and Economic Burden of Endometrial Cancer Pharmacy Times

Published: April 17, 2026, 12:30 p.m.
A Chemo-Free Option for Some Advanced Endometrial Cancers? - Medscape

A Chemo-Free Option for Some Advanced Endometrial Cancers? Medscape

Published: April 17, 2026, 11:26 a.m.
The impact of endocrine-disrupting chemicals on uterine diseases.

Endocrine-disrupting chemicals (EDCs) are a global concern for human health and the environment. EDCs include plasticizers, pharmaceutical agents, industrial chemicals, fungicides, and pesticides. Thus, EDC exposure is a manmade consequence …

Published: April 17, 2026, midnight
Doctor Calls Bispecific Results “Phenomenal” in Advanced Endometrial Cancer Trial - CU Anschutz newsroom

Doctor Calls Bispecific Results “Phenomenal” in Advanced Endometrial Cancer Trial CU Anschutz newsroom

Published: April 16, 2026, 11:26 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!